reglab/housing_qa huggingface dataset:
GA Code § 26-4-146 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 8 - Third-Party Prescription Programs|§ 26-4-146. Administrator; Registration; Bond

  On and after January 1, 1984, no person, corporation, or business entity shall serve as administrator of a program which has no administrator registered under this Code section unless that person, corporation, or business entity is registered as administrator of that program with the Commissioner.   No administrator may be registered unless the administrator gives bond to the Commissioner conditioned to pay all losses, damages, and expenses incurred as a result of any violation of this article by the administrator or the program being administered thereby. The bond shall be with a surety approved by the Commissioner in the amount of $200,000.00 or the total annual payments made in the immediately preceding year by all programs administered by that administrator, whichever is greater; provided, however, if the administrator is an insurance company licensed to transact insurance in this state or if the administrator is a self-insurer and is approved by the Commissioner, then such administrator shall not be required to give bond to the Commissioner.   No program shall be required to have more than one administrator registered and bonded under this Code section.   An administrator may have his or her registration suspended or revoked by the Commissioner upon any violation of this article by the administrator or when any program administered by the administrator fails to conform to the requirements of this article. The refusal by the Commissioner to register an administrator and the suspension or revocation of an administrator's registration shall constitute a contested case for purposes of Chapter 13 of Title 50, the "Georgia Administrative Procedure Act."   Records, information, and other identifying matter obtained through the submission of a claim for reimbursement by a participating pharmacy shall be used exclusively and solely for the purposes of verification and payment to the participating pharmacy and policyholder and for no other purposes.     (Code 1981, §26-4-146, enacted by Ga. L. 1998, p. 686, § 1; Ga. L. 1999, p. 81, § 26.)
GA Code § 26-4-147 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 8 - Third-Party Prescription Programs|§ 26-4-147. Liability of Enrollees

 No enrollee may utilize a program identification card to obtain pharmaceuticals after the program has been canceled and after the enrollee has received notification of the cancellation, and if such card is so utilized, that enrollee shall be liable to the administrator of that program for the cost of those pharmaceuticals.    (Code 1981, §26-4-147, enacted by Ga. L. 1998, p. 686, § 1.)
GA Code § 26-4-148 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 8 - Third-Party Prescription Programs|§ 26-4-148. Violations of Article; Penalties

  Any person, corporation, or business entity which violates subsection (a) of Code Section 26-4-146 shall be guilty of a misdemeanor.   Any person, corporation, or business entity which violates any provision of this article shall be subject to a civil penalty in the amount of $1,000.00 for each act in violation of this article or, if the violation was knowing and willful, a civil penalty of $5,000.00 for each act in violation of this article.   Any person injured as a result of a violation of this article may bring an action against that person, corporation, or business entity violating this article for the recovery of all actual damages occurring as a result thereof, plus attorneys' fees.   An action may be brought against any person, corporation, or business entity subject to civil penalties or an action for damages under this Code section in the county in this state in which the person resides or corporation or business entity maintains an office or, if neither residing nor maintaining an office in this state, in the Superior Court of Fulton County.   All penalties and remedies provided in this Code section are cumulative of each other and of any other penalties and remedies otherwise provided by law.     (Code 1981, §26-4-148, enacted by Ga. L. 1998, p. 686, § 1.)
GA Code § 26-4-160 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 9 - Poisons|§ 26-4-160. Sales and Labeling

 No person shall furnish by retail sale any poison enumerated in this Code section without distinctly labeling the bottle, box, vessel, or paper in which the poison is contained, and also the outside wrapper or cover thereof, with the name of the article, the word "Poison," and the name and place of business of the person who furnishes the same; and no poison shall be furnished unless upon due inquiry it shall be found that the person to whom it is delivered is aware of its poisonous character and shall represent that it is to be used for a legitimate purpose:    Schedule "A." Arsenic and its preparations, corrosive sublimate, white precipitate, red precipitate, biniodide of mercury, cyanide of potassium, hydrocyanic acid, strychnia, and all other poisonous vegetable alkaloids and their salts; essential oil of bitter almonds, opium and its preparations, except paregoric and other preparations of opium containing less than two grains to the ounce; and   Schedule "B." Aconite, belladonna, colchicum, conium, nux vomica, henbane, creosote, digitalis, and their pharmaceutical preparations; croton oil, chloroform, chloral hydrate, sulfate of zinc, mineral acids, carbolic acid, and oxalic acid.     (Code 1981, §26-4-160, enacted by Ga. L. 1998, p. 686, § 1.)
GA Code § 26-4-161 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 9 - Poisons|§ 26-4-161. Procedure on Sale or Delivery of Listed Poisons

 No licensed pharmacist shall sell or deliver any of the poisons included in paragraph (1) of Code Section 26-4-160 without first making an entry in a book for that purpose, stating the date of the delivery, the name and address of the person receiving the poison, the name and quantity of the poison, the purpose for which it is represented by such person to be required, and the name of the dispenser. Such book shall always be open for inspection by the proper authorities and shall be preserved for reference for at least five years.    (Code 1981, §26-4-161, enacted by Ga. L. 1998, p. 686, § 1.)
GA Code § 26-4-162 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 9 - Poisons|§ 26-4-162. Prescriptions by Practitioners of the Healing Arts

 This article shall not apply to the dispensing of poisons in not unusual quantities or doses, upon the prescriptions of practitioners of the healing arts.    (Code 1981, §26-4-162, enacted by Ga. L. 1998, p. 686, § 1.)
GA Code § 26-4-163 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 9 - Poisons|§ 26-4-163. Penalty for Violation of Article

 Any person violating this article shall be guilty of a misdemeanor.    (Code 1981, §26-4-163, enacted by Ga. L. 1998, p. 686, § 1.)
GA Code § 26-4-170 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 10 - Nuclear Pharmacy Law|§ 26-4-170. Short Title

 This article shall be known and may be cited as the "Nuclear Pharmacy Law."    (Code 1981, §26-4-170, enacted by Ga. L. 1999, p. 277, § 10.)
GA Code § 26-4-171 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 10 - Nuclear Pharmacy Law|§ 26-4-171. Definitions

 As used in this article, the term:    "Authentication of product history" means, but is not limited to, identifying the purchasing source, the ultimate fate, and any intermediate handling of any component of a radiopharmaceutical.   "Board" means the State Board of Pharmacy.   "Compounding of radiopharmaceuticals" means the addition of a radioactive substance to nonradioactive substances or the use of a radioactive substance in preparation for single or multidose dispensation upon the prescription order of a physician who is licensed to use radioactive materials. Compounding of radiopharmaceuticals may include: loading and eluting of radionuclide generators; using manufactured reagent kits to prepare radiopharmaceuticals; preparing reagent kits; aliquoting reagents; formulation and quality assurance testing of radiochemicals for use as radiopharmaceuticals; and radiolabeling of compounds or products, including biological products, for use as radiopharmaceuticals.   "Department" means the Department of Natural Resources.   "Internal test assessment" means, but is not limited to, conducting those tests of quality assurance necessary to ensure the integrity of the test.   "Manufacturing of radiopharmaceuticals" means the preparation, derivation, or production of a product to which a radioactive substance is or will be added to provide a radiopharmaceutical for sale, resale, redistribution, or reconstitution.   "Nuclear pharmacy" means a pharmacy providing radiopharmaceutical service.   "Radiopharmaceutical" means radioactive drugs and chemical products used for diagnostic and therapeutic purposes and includes the terms radioactive pharmaceuticals, radioisotopes, and radioactive tracers.   "Radiopharmaceutical quality assurance" means, but is not limited to, the performance of appropriate chemical, biological, and physical tests on radiopharmaceuticals and their component materials and the interpretation of the resulting data to determine their suitability for use in humans and animals, including internal test assessment, authentication of product history, and the keeping of proper records.   "Radiopharmaceutical service" means, but is not limited to, the compounding, dispensing, labeling, and delivering of radiopharmaceuticals; the participation in radiopharmaceutical selection and radiopharmaceutical utilization review; the maintenance of radiopharmaceutical quality assurance; and the responsibility for advising, where necessary or where regulated, of therapeutic values, hazards, and use of radiopharmaceuticals; and the offering or performing of those acts, services, operations, or transactions necessary in the conduct, operation, management, and control of a nuclear pharmacy.     (Code 1981, §26-4-171, enacted by Ga. L. 1999, p. 277, § 10.)
GA Code § 26-4-172 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 10 - Nuclear Pharmacy Law|§ 26-4-172. License Requirements Generally

  All persons, firms, pharmacies, or corporations which receive, possess, transfer, or manufacture for sale or resale radiopharmaceuticals shall be licensed in accordance with the provisions of this article. No person may receive, acquire, possess, compound, or dispense any radiopharmaceutical except in accordance with the provisions of this article and the conditions of rules and regulations promulgated by the Board of Natural Resources for radioactive materials and administered by the department. The requirements of this article are in addition to, and not in substitution of, other applicable statutes and regulations administered by the State Board of Pharmacy or the department.   Nothing in this article shall be construed as requiring a licensed physician to obtain a separate license as a nuclear pharmacist, when his or her use of radiopharmaceuticals is limited to the diagnosis and treatment of his or her own patients.   Nothing in this article shall be construed so as to require a clinical laboratory certified by the federal Centers for Medicare and Medicaid Services, which is licensed by the Department of Community Health to handle radioactive materials, to obtain the services of a nuclear pharmacist, or to have a nuclear pharmacy license, unless the laboratory is engaged in the commercial sale or resale of radiopharmaceuticals.   Nothing in this article shall be construed to require a department of nuclear medicine which is located in a hospital of 250 beds or less, which has a board certified radiologist in the practice of nuclear medicine, and which is licensed by the department to handle radioactive materials to obtain the services of a nuclear pharmacist or to have a nuclear pharmacy license.     (Code 1981, §26-4-172, enacted by Ga. L. 1999, p. 277, § 10; Ga. L. 2009, p. 453, § 1-4/HB 228; Ga. L. 2021, p. 472, § 2/HB 93.)    The 2021 amendment,  effective July 1, 2021, substituted "require a clinical laboratory certified by the federal Centers for Medicare and Medicaid Services" for "require a licensed clinical laboratory" near the beginning of subsection (c).
GA Code § 26-4-173 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 10 - Nuclear Pharmacy Law|§ 26-4-173. Applicant Requirements

  An applicant for a license as a nuclear pharmacist shall:   Be a currently licensed pharmacist in the State of Georgia;   Meet the minimum requirements and be licensed to possess and use radioactive materials for medical use, as authorized by the department; and   Have met all requirements for training and experience established by the board in rules and regulations promulgated pursuant to this authority; provided, however, rules and regulations prescribing training and experience requirements for nuclear pharmacists shall have first been approved by the department.     A license as a nuclear pharmacist shall be issued to any pharmacist who makes application to the board, together with a required fee, and meets the requirements of subsection (a) of this Code section.     (Code 1981, §26-4-173, enacted by Ga. L. 1999, p. 277, § 10.)
GA Code § 26-4-175 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 10 - Nuclear Pharmacy Law|§ 26-4-175. Meeting Requirements of the Board

 Nuclear pharmacies shall meet all requirements for items and articles of equipment as required through rules and regulations of the board. Nuclear pharmacies shall also have equipment required for the safe handling and storage of radioactive materials, as established by rules of the department.    (Code 1981, §26-4-175, enacted by Ga. L. 1999, p. 277, § 10.)
GA Code § 26-4-176 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 10 - Nuclear Pharmacy Law|§ 26-4-176. Limiting, Suspending, or Revoking License

 The board may limit, suspend, or revoke licenses issued under the provisions of this article, or impose any other reasonable sanctions upon holders of such licenses upon proof of any of the violations specified in Code Sections 26-4-60 and 26-4-113.    (Code 1981, §26-4-176, enacted by Ga. L. 1999, p. 277, § 10.)
GA Code § 26-4-177 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 10 - Nuclear Pharmacy Law|§ 26-4-177. Board Refusing to Grant License

 The board may refuse to grant a license to any person, firm, or corporation for any of the grounds set forth in Code Sections 26-4-60 and 26-4-113. In addition, the board may refuse to grant a license if any applicant shall make any false statement in the application or cheats in any manner upon any examination administered pursuant to this article.    (Code 1981, §26-4-177, enacted by Ga. L. 1999, p. 277, § 10.)
GA Code § 26-4-178 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 10 - Nuclear Pharmacy Law|§ 26-4-178. Authorized to Promulgate Rules

 The board is authorized to promulgate rules and regulations to implement the provisions of this article.    (Code 1981, §26-4-178, enacted by Ga. L. 1999, p. 277, § 10.)
GA Code § 26-4-179 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 10 - Nuclear Pharmacy Law|§ 26-4-179. Authority of Department

 Nothing in this article shall be construed to repeal the authority of the Department of Natural Resources to regulate the use of radioactive materials.    (Code 1981, §26-4-179, enacted by Ga. L. 1999, p. 277, § 10.)
GA Code § 26-4-190 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 11 - Utilization of Unused Prescription Drugs|§ 26-4-190. Through 26-4-195

 Reserved. Repealed by Ga. L. 2016, p. 524, § 2/HB 897, effective July 1, 2016.   Editor's notes.   - This Article was based on Code 1981, § 26-4-190, enacted by Ga. L. 2006, p. 152, § 1/HB 1178; Ga. L. 2009, p. 453, § 1-21/HB 228; Ga. L. 2011, p. 227, § 8/SB 178; Ga. L. 2011, p. 705, § 5-8/HB 214.
GA Code § 26-4-200 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 12 - Prescription Medication Integrity Act|§ 26-4-200. (For Effective Date, See note.) Short Title

 This article shall be known and may be cited as the "Prescription Medication Integrity Act."    (Code 1981, §26-4-200, enacted by Ga. L. 2007, p. 463, § 2/SB 205.)   Editor's notes.   - For information as to the effective date of this Code section, see the delayed effective date note at the beginning of this article.
GA Code § 26-4-203 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 12 - Prescription Medication Integrity Act|§ 26-4-203. (For Effective Date, See note.) Violations; Falsified Prescription Drugs

  If the board finds that there is a reasonable probability that:   A wholesale distributor, other than a manufacturer, has:   Violated a provision of this article; or   Falsified a pedigree, provided a falsified pedigree, or sold, distributed, transferred, manufactured, repackaged, handled, or held a counterfeit prescription drug intended for human use;     The prescription drug at issue in subparagraph (B) of paragraph (1) of this subsection could cause serious, adverse health consequences or death; and   Other procedures would result in unreasonable delay,  the board shall issue an order requiring the appropriate person including the distributors or retailers of the prescription drug to immediately cease distribution of the prescription drug in or to this state.      An order under subsection (a) of this Code section shall provide the person subject to the order with an opportunity for an informal hearing, to be held not later than ten calendar days after the date of the issuance of the order, on the actions required by the order. If, after such a hearing, the board determines that inadequate grounds exist to support the actions required by the order, the board shall vacate the order.     (Code 1981, §26-4-203, enacted by Ga. L. 2007, p. 463, § 2/SB 205.)   Editor's notes.   - For information as to the effective date of this Code section, see the delayed effective date note at the beginning of this article.
GA Code § 26-4-204 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 12 - Prescription Medication Integrity Act|§ 26-4-204. (For Effective Date, See note.) Prohibited Acts

 It shall be unlawful for a person to perform or cause the performance of or aid and abet any of the following acts in this state:    Selling, distributing, or transferring a prescription drug to a person that is not authorized to receive the prescription drug under the law of the jurisdiction in which the person receives the prescription drug;   Failing to maintain or provide pedigrees as required by the board;   Failing to obtain, transfer, or authenticate a pedigree as required by the board;   Providing the board or any of its representatives or any federal official with false or fraudulent records, including, but not limited to falsified pedigrees, or making false or fraudulent statements regarding any matter within the provisions of this article;   Obtaining or attempting to obtain a prescription drug by fraud, deceit, or misrepresentation or engaging in misrepresentation or fraud in the distribution of a prescription drug; and   Except for the wholesale distribution by manufacturers of a prescription drug that has been delivered into commerce pursuant to an application approved under federal law by the Food and Drug Administration, the manufacturing, repackaging, selling, transferring, delivering, holding, or offering for sale of any prescription drug that is adulterated, misbranded, counterfeit, suspected of being counterfeit, or has otherwise been rendered unfit for distribution.     (Code 1981, §26-4-204, enacted by Ga. L. 2007, p. 463, § 2/SB 205.)   Editor's notes.   - For information as to the effective date of this Code section, see the delayed effective date note at the beginning of this article.
GA Code § 26-4-205 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 12 - Prescription Medication Integrity Act|§ 26-4-205. (For Effective Date, See note.) Penalty

  Notwithstanding Code Section 26-4-115, any person who engages without knowledge in the wholesale distribution of prescription drugs, including providing a falsified pedigree or other records, in violation of this article may be fined not more than $10,000.00.   If a person engages in wholesale distribution of prescription drugs in violation of this article, including providing a falsified pedigree or other records, and acts in a grossly negligent manner in violation of this article, the person may be punished by imprisonment for not more than 15 years, fined not more than $50,000.00, or both.   Notwithstanding Code Section 26-4-115, any person who knowingly engages in wholesale distribution of prescription drugs in violation of this article, including providing a falsified pedigree or other records, shall be guilty of a felony and, upon conviction thereof, shall be punished by imprisonment for not more than 25 years, by fine not to exceed $500,000.00, or both.     (Code 1981, §26-4-205, enacted by Ga. L. 2007, p. 463, § 2/SB 205.)   Editor's notes.   - For information as to the effective date of this Code section, see the delayed effective date note at the beginning of this article.
GA Code § 26-4-210 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 13 - Safe Medications Practice Act|§ 26-4-210. Short Title

 This article shall be known and may be cited as the "Safe Medications Practice Act."    (Code 1981, §26-4-210, enacted by Ga. L. 2010, p. 195, § 1/HB 361.)
GA Code § 26-4-211 (2021)
2021 Georgia Code|Title 26 - Food, Drugs, and Cosmetics|Chapter 4 - Pharmacists and Pharmacies|Article 13 - Safe Medications Practice Act|§ 26-4-211. Legislative Findings and Intent

  The General Assembly finds and declares that:   Medications are essential for the effective treatment and prevention of illness and disease, and medications, particularly dangerous drugs, are recognized to be complex chemical compounds which may cause untoward side effects, adverse reactions, and other undesirable and potentially harmful effects;   Hospital pharmacists are highly trained in the therapeutic use of medications and have expertise in the safe, appropriate, and cost-effective use of medications; and   Therefore, it is essential that physicians, pharmacists, and other clinical health care practitioners in an institutional setting collaborate to promote safe and effective medication therapy for the institution's patients.     The intent of the General Assembly in enacting this legislation is to maximize patient safety, to ensure safe and desirable medication therapy outcomes, and to achieve desired therapeutic goals.     (Code 1981, §26-4-211, enacted by Ga. L. 2010, p. 195, § 1/HB 361.)